Präsentationen & Videos

Videos

Finanzjahr 2024/25

BRAIN Biotech AG Financial Results FY 2024 / 25 | Monetization, Margins & Enzyme growth initiatives

In the FY 2024/25 results presentation, Michael Schneiders, Chief Financial Officer, outlines how Brain Biotech is progressing from a technology-driven innovation platform toward a more cash-generative, scalable industrial biotechnology group.

Deep Dive 2025 | AI-Driven Enzyme Discovery, U.S. Expansion, and Growth Strategy

Michael Schneiders, CFO of BRAIN Biotech AG, adresses the seven most frequently asked questions from institutional investors,  providing insights, perspectives, and a forward-looking outlook on topics ranging from AI-powered enzyme discovery and U.S. expansion to M&A strategy and the commercial pipeline within the BRAINBioIncubator portfolio.

BRAIN Biotech AG Financial Results 9M 2024 / 25

CFO Michael Schneiders: Strong Core Growth & BioIncubator Innovations

BRAIN Biotech AG Elevator Pitch 2025 | Strategie und Visionen

CFO Michael Schneiders: Strategie und Visionen der BRAIN Biotech AG
(Aufnahmedatum: 4. Juni 2025)

BRAIN Biotech AG Financial Results H1 2024/25

CFO Michael Schneiders: Financial Results H1 2024/25 | Innovation Momentum and Strategic Focus

BRAIN Biotech AG Financial Results Q1 2024/25

CFO Michael Schneiders: Financial Results Q1 2024/25 | Growth, Innovation & Outlook

Alle älteren Videos finden Sie auf der Plattform von Seat11a

Kontakt